# Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)

> **NCT05860114** · PHASE1 · COMPLETED · sponsor: **Italfarmaco** · enrollment: 8 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** Givinostat

## Key facts

- **NCT ID:** NCT05860114
- **Lead sponsor:** Italfarmaco
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2022-05-08
- **Final completion:** 2022-05-24
- **Target enrollment:** 8 (ACTUAL)
- **Last updated:** 2025-01-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05860114

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05860114, "Givinostat and Metabolites Pharmacokinetics in Urine and Plasma (Part 3)". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05860114. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*